BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16792133)

  • 1. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.
    Westhoff TH; Schmidt S; Zidek W; Beige J; van der Giet M
    Clin Nephrol; 2006 Jun; 65(6):393-400. PubMed ID: 16792133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience.
    Ramachandran R; Kumar V; Rathi M; Nada R; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrol Dial Transplant; 2014 Oct; 29(10):1918-24. PubMed ID: 24771498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Tang S; Tang AW; Tam MK; Ho YW
    Am J Kidney Dis; 2003 Nov; 42(5):E13-5. PubMed ID: 14582073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure.
    Li X; Xu N; Li H; Han F; Wang R; He Q; He X; Chen J
    Nephrol Dial Transplant; 2013 Sep; 28(9):2306-12. PubMed ID: 23787554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
    Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C
    Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective therapy of a child case of refractory nephrotic syndrome with tacrolimus.
    Tsugawa K; Tanaka H; Nakahata T; Ito E
    Tohoku J Exp Med; 2004 Nov; 204(3):237-41. PubMed ID: 15502424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure.
    Moura LR; Franco MF; Kirsztajn GM
    J Bras Nefrol; 2015; 37(4):475-80. PubMed ID: 26648497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial.
    Fan L; Liu Q; Liao Y; Li Z; Ji Y; Yang Z; Chen J; Fu J; Zhang J; Kong Y; Fu P; Lou T; Liu Z; Yu X; Chen W
    Int Urol Nephrol; 2013 Apr; 45(2):459-68. PubMed ID: 22684795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.
    Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Takeda A; Tsukamoto T; Uchida S; Tsuruya K; Shoji T; Hayashi H; Akai Y; Fukunaga M; Konta T; Nishio S; Goto S; Tamai H; Nagai K; Katafuchi R; Masutani K; Wada T; Nishino T; Shirasaki A; Sobajima H; Nitta K; Yamagata K; Kazama JJ; Hiromura K; Yasuda H; Mizutani M; Akahori T; Naruse T; Hiramatsu T; Morozumi K; Mimura T; Saka Y; Ishimura E; Hasegawa H; Ichikawa D; Shigematsu T; Sato H; Narita I; Isaka Y;
    J Nephrol; 2022 May; 35(4):1135-1144. PubMed ID: 35366214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults.
    Chin HJ; Chae DW; Kim YC; An WS; Ihm C; Jin DC; Kim SG; Kim YL; Kim YS; Kim YG; Koo HS; Lee JE; Lee KW; Oh J; Park JH; Jiang H; Lee H; Lee SK
    J Am Soc Nephrol; 2021 Jan; 32(1):199-210. PubMed ID: 33168602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
    Heering P; Braun N; Müllejans R; Ivens K; Zäuner I; Fünfstück R; Keller F; Krämer BK; Schollmeyer P; Risler T; Grabensee B;
    Am J Kidney Dis; 2004 Jan; 43(1):10-8. PubMed ID: 14712422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Brodehl J; Brandis M; Helmchen U; Hoyer PF; Burghard R; Ehrich JH; Zimmerhackl RB; Klein W; Wonigeit K
    Klin Wochenschr; 1988 Nov; 66(22):1126-37. PubMed ID: 3236762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome.
    Gargah TT; Lakhoua MR
    J Nephrol; 2011; 24(2):203-7. PubMed ID: 21319130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J; Ehrich JH; Querfeld U
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.